FDA approves first generic Strattera for the treatment of ADHD
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients. (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 30, 2017 Category: American Health Source Type: news
FDA Approves First Generic Strattera for the Treatment of ADHD
May 30, 2017 -- The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
Apotex Inc., Teva Pharmaceuticals... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 30, 2017 Category: Pharmaceuticals Source Type: news
Vyvanse vs. Strattera
Title: Vyvanse vs. StratteraCategory: MedicationsCreated: 2/23/2017 12:00:00 AMLast Editorial Review: 2/23/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 23, 2017 Category: Drugs & Pharmacology Source Type: news
Atomoxetine vs. Adderall
Title: Atomoxetine vs. AdderallCategory: MedicationsCreated: 1/27/2017 12:00:00 AMLast Editorial Review: 1/27/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - January 27, 2017 Category: Drugs & Pharmacology Source Type: news
Strattera (Atomoxetine HCl) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 12, 2016 Category: Drugs & Pharmacology Source Type: news
Strattera (atomoxetine)
Title: Strattera (atomoxetine)Category: MedicationsCreated: 1/22/2003 12:00:00 AMLast Editorial Review: 9/9/2016 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 9, 2016 Category: Drugs & Pharmacology Source Type: news
Atomoxetine improves critical reading skills in children with dyslexia
(Mary Ann Liebert, Inc./Genetic Engineering News) A new study shows significant improvement in critical components of reading, including decoding and vocabulary, among children treated with atomoxetine compared to placebo. Atomoxetine treatment was also associated with significant reductions in symptoms of attention-deficit/hyperactivity disorder (ADHD) in children with both dyslexia and ADHD or ADHD alone, as reported in the study published in Journal of Child and Adolescent Psychopharmacology. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 7, 2016 Category: Global & Universal Source Type: news
Risk of suicidal events with atomoxetine compared to stimulant treatment: a cohort study - Linden S, Bussing R, Kubilis P, Gerhard T, Segal R, Shuster JJ, Winterstein AG.
BACKGROUND: Antidepressant effects on increased suicidality in children have raised public concern in recent years. Approved in 2002 for attention-deficit/hyperactivity disorder treatment, the selective noradrenalin-reuptake-inhibitor atomoxetine was initi... (Source: SafetyLit)
Source: SafetyLit - June 4, 2016 Category: Global & Universal Tags: Age: Adolescents Source Type: news
No increased suicide risk from atomoxetine in youths with ADHD
Youths who take atomoxetine for attention-deficit/hyperactivity disorder or other mental health conditions do not appear any more likely to attempt or complete suicide than those treated with... (Source: Family Practice News)
Source: Family Practice News - April 26, 2016 Category: Primary Care Source Type: news
No increased suicide risk from atomoxetine in youths with ADHD
Youths who take atomoxetine for attention-deficit/hyperactivity disorder or other mental health conditions do not appear any more likely to attempt or complete suicide than those treated with... (Source: Pediatric News)
Source: Pediatric News - April 26, 2016 Category: Journals (General) Source Type: news
Solving the Puzzle of Your ADD/ADHD Child: Natural Alternatives for Hard-to-Raise Children
Raising any child can feel like a puzzle. However, when your child has ADD or ADHD, that puzzle can seem to have a few missing pieces. This was the case for Laura J. Stevens with her first son, Tommy. As she describes in Solving the Puzzle of Your ADD/ADHD Child: Natural Alternatives for Hard-to-Raise Children, when Tommy was four, a pediatric neurologist concluded that he was hyperactive and “would probably experience sever learning problems in school and always require special education classes.”
Something about that conclusion didn’t sit well with Stevens, who has a master’s degree in nutritional science and h...
Source: Psych Central - February 13, 2016 Category: Psychiatry Authors: Claire Nana Tags: Attention Deficit Disorder Book Reviews Children and Teens Diet & Nutrition General Healthy Living School Issues adhd food adhd home remedies adhd natural remedies bad food for add books on add books on adhd books on children wit Source Type: news
Differences in abuse potential of ADHD drugs measured by contrasting poison centre and therapeutic use data - Jensen LS, Pagsberg AK, Dalhoff KP.
Context. Atomoxetine (ATX) is the treatment of choice for attention deficit hyperactivity disorders with co-morbid risk of drug abuse, although its abuse potential needs to be qualified. The purpose of this study is to analyse ATX misuse in relation to the... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - November 21, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
Attention deficit hyperactivity disorder medication use among teens and young adults - Johansen ME, Matic K, McAlearney AS.
PURPOSE: The purpose of this study was to determine rates of stimulant/atomoxetine use among teens (aged 12-17 years) and young adults (aged 18-23 years) and to investigate associations in medication use before and after the transition from teen to young a... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - June 5, 2015 Category: Global & Universal Tags: Age: Adolescents Source Type: news
The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine - Pringsheim T, Hirsch L, Gardner D, Gorman DA.
OBJECTIVE: Children with attention-deficit hyperactivity disorder (ADHD) may have oppositional behaviour, conduct problems, and aggression. These symptoms vary in severity, and may be related to a comorbid diagnosis of oppositional defiant disorder (ODD) o... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 24, 2015 Category: Global & Universal Tags: Age: Adolescents Source Type: news
Efficacy of atomoxetine for symptoms of attention-deficit/hyperactivity disorder in children with a history of child abuse - Sugimoto A, Suzuki Y, Endo T, Matsumoto K, Sugiyama T, Someya T.
OBJECTIVE: Recent studies suggest that the severity and drug response of depression and anxiety are correlated with childhood abuse. However, whether a history of child abuse can predict the severity and/or drug response of attention-deficit/hyperactivity ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 23, 2015 Category: Global & Universal Tags: Age: Adolescents Source Type: news
